South African AIDS Vaccine Initiative explained

The South African AIDS Vaccine Initiative (SAAVI) was a South African organisation with the mission of coordinating the research and development of HIV vaccines in and for South Africa.[1] [2] The organization closed on 31 December 2012.[3]

History

SAAVI was established in 1999 by the South African government as a project of the South African Medical Research Council. SAAVI frequently partnered with the HIV Vaccine Trials Network.

Funding problems

In June 2009, SAAVI announced that it was testing a new HIV vaccine candidate but suspended all further vaccine development indefinitely due to lack of funds.[4]

Notes and References

  1. Tucker. Timothy J. Mazithulela. Gatsha. 2004-08-21. Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative. BMJ: British Medical Journal. 329. 7463. 454–456. 10.1136/bmj.329.7463.454. 0959-8138. 15321907. 514216.
  2. Birmingham. Karen. 2000-08-01. HIV vaccine trials planned for Africa. Nature Medicine. en. 6. 8. 844. 10.1038/78569. 10932201. 1546-170X. free.
  3. Web site: SAAVI . saavi.org.za.
  4. Web site: South Africa launches AIDS vaccine trial but slashes research funding . Michelle . Faul . . washingtonexaminer.com . 20 June 2009 . 24 June 2011.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "South African AIDS Vaccine Initiative".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.